ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,251Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 2680

$1.71M Total Retail Price of All Prescriptions

Rank: 8 out of 2680

372 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 19,725 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 612 604 1 3
CARVEDILOL 522 496 2 27
ZOLPIDEM TARTRATE 520 508 3 17
LOVAZA 491 458 4 47
SYNTHROID 461 456 5 39
SIMVASTATIN 458 435 6 1
PLAVIX 456 449 7 41
ATORVASTATIN CALCIUM 442 430 8 10
ISOSORBIDE MONONITRATE ER 406 400 9 57
METOPROLOL SUCCINATE 394 394 10 11
FUROSEMIDE 390 390 11 7
NEXIUM 390 381 11 19
LIPITOR 375 375 13 78
HYDRALAZINE HCL 361 344 14 99
METFORMIN HCL 289 267 15 6
RAMIPRIL 255 255 16 49
CREON 237 233 17 112
CLOPIDOGREL 233 219 18 30
CRESTOR 230 219 19 15
METOPROLOL TARTRATE 230 230 19 8
RANEXA 230 230 19 173
LISINOPRIL 227 216 22 5
FAMOTIDINE 214 214 23 65
CLONIDINE HCL 205 195 24 84
BYSTOLIC 201 201 25 104
LIDODERM 190 190 26 74
ZETIA 187 172 27 69
COUMADIN 185 185 28 154
TAMSULOSIN HCL 172 169 29 25
DIOVAN 172 172 29 26
HYDROCHLOROTHIAZIDE 165 161 31 9
NAMENDA 163 163 32 43
LEVOTHYROXINE SODIUM 163 154 32 4
TRILIPIX 158 147 34 151
BENICAR 149 149 35 122
ATENOLOL 147 147 36 14
LOSARTAN POTASSIUM 141 139 37 18
VYTORIN 131 131 38 200
LEXAPRO 129 129 39 218
OMEPRAZOLE 128 112 40 2
VOLTAREN 127 122 41 103
COREG CR 126 126 42 292
DONEPEZIL HCL 124 124 43 28
DIOVAN HCT 123 123 44 54
ALLOPURINOL 121 121 45 42
AVODART 121 121 45 165
JANUVIA 119 118 47 34
LANSOPRAZOLE 116 116 48 121
DIGOXIN 114 114 49 59
GABAPENTIN 113 102 50 21
METFORMIN HCL ER 112 104 51 53
MICARDIS HCT 108 108 52 205
PRANDIN 106 106 53 191
WARFARIN SODIUM 104 104 54 12
MICARDIS 104 93 54 219
EVISTA 101 89 56 92
DILTIAZEM 24HR CD 98 98 57 148
BENICAR HCT 98 93 57 125
FLUOCINONIDE 97 95 59 211
ESCITALOPRAM OXALATE 94 94 60 82
ALENDRONATE SODIUM 92 91 61 20
CLOTRIMAZOLE-BETAMETHASONE 90 90 62 109
CELEBREX 89 87 63 75
LOSARTAN-HYDROCHLOROTHIAZIDE 89 88 63 46
GLIMEPIRIDE 89 89 63 51
POTASSIUM CHLORIDE 89 89 63 29
DEXILANT 85 85 67 133
AMITIZA 84 81 68 190
SERTRALINE HCL 83 83 69 23
MECLIZINE HCL 83 83 69 105
TOPROL XL 83 83 69 386
LIDOCAINE 82 72 72 186
CILOSTAZOL 82 82 72 263
NIFEDIPINE ER 78 74 74 73
RANITIDINE HCL 71 71 75 35
CYMBALTA 70 69 76 56
SINGULAIR 68 67 77 64
DICYCLOMINE HCL 67 56 78 267
FINASTERIDE 67 65 78 80
MELOXICAM 64 64 80 50
SPIRIVA 63 53 81 36
PROAIR HFA 63 54 81 52
PROCTOSOL-HC 61 61 83 452
TRAZODONE HCL 61 61 83 60
ADVAIR DISKUS 59 54 85 32
AZITHROMYCIN 59 59 85 40
TORSEMIDE 57 57 87 169
TRIAMTERENE-HCTZ 56 56 88 89
NITROSTAT 56 56 88 291
SINGLE USE SWAB 55 55 90 196
ENALAPRIL MALEATE 55 46 90 24
PRAVASTATIN SODIUM 55 55 90 16
CHLORHEXIDINE GLUCONATE 54 54 93 166
IBUPROFEN 51 47 94 63
CLOBETASOL PROPIONATE 51 49 94 231
PROCTOZONE-HC 50 50 96 280
SOLARAZE 50 50 96 172
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.